Nail disorders in hemodialysis patients and renal transplant recipients: a case-control study. 2004

Yasemin Saray, and Deniz Seçkin, and Ayse Tülin Güleç, and Seval Akgün, and Mehmet Haberal
Department of Dermatology, Başkent University Faculty of Medicine, Ankara, Turkey. yaseminsaray@hotmail.com

BACKGROUND There is one published case-control study of nail disorders in hemodialysis patients. The nail changes that occur in renal transplant recipients have not been investigated specifically. OBJECTIVE The aim of this study was to determine prevalence rates of nail disorders in hemodialysis patients and renal transplant recipients, and to investigate whether these nail pathologies are related to hemodialysis and renal transplantation. METHODS One hundred and eighty-two hemodialysis patients and 205 renal transplant recipients were screened for the presence of nail disorders. The findings in these groups were compared with findings in 143 healthy individuals. RESULTS One hundred and twenty-seven patients (69.8%) in the hemodialysis group and 116 patients (56.6%) in the renal transplant recipients had at least one type of nail pathology. Absence of lunula, splinter hemorrhage, and half-and-half nails were significantly more common in the hemodialysis patients than in the renal transplant recipients. Leukonychia was significantly more frequent in the renal transplant recipients than in the hemodialysis patients and controls. CONCLUSIONS Hemodialysis patients and renal transplant recipients have higher rates of nail disease than the healthy population. Renal transplantation may reduce the frequencies of splinter hemorrhage and half-and-half nails. Interestingly, leukonychia increases significantly after renal transplantation.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009260 Nail Diseases Diseases of the nail plate and tissues surrounding it. The concept is limited to primates. Disease, Nail,Diseases, Nail,Nail Disease
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Yasemin Saray, and Deniz Seçkin, and Ayse Tülin Güleç, and Seval Akgün, and Mehmet Haberal
September 2017, Lung cancer (Amsterdam, Netherlands),
Yasemin Saray, and Deniz Seçkin, and Ayse Tülin Güleç, and Seval Akgün, and Mehmet Haberal
January 2013, Clinical transplantation,
Yasemin Saray, and Deniz Seçkin, and Ayse Tülin Güleç, and Seval Akgün, and Mehmet Haberal
March 2022, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation,
Yasemin Saray, and Deniz Seçkin, and Ayse Tülin Güleç, and Seval Akgün, and Mehmet Haberal
February 1999, Clinical transplantation,
Yasemin Saray, and Deniz Seçkin, and Ayse Tülin Güleç, and Seval Akgün, and Mehmet Haberal
February 2001, Kidney international. Supplement,
Yasemin Saray, and Deniz Seçkin, and Ayse Tülin Güleç, and Seval Akgün, and Mehmet Haberal
March 2007, Journal of the European Academy of Dermatology and Venereology : JEADV,
Yasemin Saray, and Deniz Seçkin, and Ayse Tülin Güleç, and Seval Akgün, and Mehmet Haberal
September 2012, Zhonghua nan ke xue = National journal of andrology,
Yasemin Saray, and Deniz Seçkin, and Ayse Tülin Güleç, and Seval Akgün, and Mehmet Haberal
January 2017, Anais brasileiros de dermatologia,
Yasemin Saray, and Deniz Seçkin, and Ayse Tülin Güleç, and Seval Akgün, and Mehmet Haberal
July 1983, JAMA,
Yasemin Saray, and Deniz Seçkin, and Ayse Tülin Güleç, and Seval Akgün, and Mehmet Haberal
January 2010, Anais brasileiros de dermatologia,
Copied contents to your clipboard!